UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$321M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$214M |
| 3 |
Zimmer Biomet
ZBH
|
+$207M |
| 4 |
Ecolab
ECL
|
+$192M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$251M |
| 2 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$225M |
| 3 |
AGN
Allergan Inc
AGN
|
+$221M |
| 4 |
Apple
AAPL
|
+$201M |
| 5 |
American Express
AXP
|
+$180M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.57% |
| 2 | Technology | 14.63% |
| 3 | Financials | 14.16% |
| 4 | Consumer Discretionary | 9.69% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Adtran
ADTN
$616M
| $414K | ﹤0.01% |
22,198
+1,200
| +6% | +$25.5K |
|
2027
Standard BioTools
LAB
$314M
| $413K | ﹤0.01% |
9,799
+500
| +5% | +$19.8K |
|
2028
OFG Bancorp
OFG
$2.21B
| $413K | ﹤0.01% |
25,298
+1,600
| +7% | +$26.7K |
|
|
ADAM
2029
Adamas Trust
ADAM
$883M
| $412K | ﹤0.01% |
13,274
+650
| +5% | +$20.3K |
|
2030
Universal Insurance Holdings
UVE
$1.23B
| $412K | ﹤0.01% |
16,100
+700
| +5% | +$16.5K |
|
2031
Coherent
COHR
$74.2B
| $410K | ﹤0.01% |
22,198
+1,100
| +5% | +$18.1K |
|
2032
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.97B
| $410K | ﹤0.01% |
+6,260
| New | +$403K |
|
|
SDRL
2033
DELISTED
Seadrill Limited Common Stock
SDRL
| $410K | ﹤0.01% |
164
| – | – |
|
2034
Seaboard Corp
SEB
$4.06B
| $409K | ﹤0.01% |
99
+4
| +4% | +$16K |
|
|
ZEN
2035
DELISTED
ZENDESK INC
ZEN
| $408K | ﹤0.01% |
+18,000
| New | +$431K |
|
|
AVX
2036
DELISTED
AVX Corporation
AVX
| $408K | ﹤0.01% |
28,596
+1,500
| +6% | +$20.7K |
|
|
DMND
2037
DELISTED
DIAMOND FOODS, INC.
DMND
| $407K | ﹤0.01% |
12,499
+400
| +3% | +$11.3K |
|
|
WSTC
2038
DELISTED
West Corporation
WSTC
| $406K | ﹤0.01% |
12,038
+2,738
| +29% | +$90.9K |
|
|
LOCK
2039
DELISTED
LifeLock, Inc.
LOCK
| $406K | ﹤0.01% |
28,799
+1,200
| +4% | +$17.1K |
|
|
PRSU
2040
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $405K | ﹤0.01% |
14,554
+700
| +5% | +$19.1K |
|
|
XOXO
2041
DELISTED
Xo Group Inc
XOXO
| $405K | ﹤0.01% |
22,898
+700
| +3% | +$11.8K |
|
|
WIBC
2042
DELISTED
WILSHIRE BANCORP INC
WIBC
| $404K | ﹤0.01% |
40,532
+2,600
| +7% | +$25.1K |
|
2043
Enova International
ENVA
$6.29B
| $402K | ﹤0.01% |
20,433
+7,900
| +63% | +$172K |
|
2044
RPC Inc
RES
$1.3B
| $400K | ﹤0.01% |
31,198
+2,000
| +7% | +$25.1K |
|
2045
ArcBest
ARCB
$3.08B
| $398K | ﹤0.01% |
10,500
+400
| +4% | +$16.2K |
|
|
EPAY
2046
DELISTED
Bottomline Technologies Inc
EPAY
| $397K | ﹤0.01% |
14,499
+600
| +4% | +$15.6K |
|
|
CGI
2047
DELISTED
Celadon Group Inc
CGI
| $397K | ﹤0.01% |
14,599
+700
| +5% | +$17.4K |
|
2048
Atlantic Union Bankshares
AUB
$5.97B
| $395K | ﹤0.01% |
17,784
+700
| +4% | +$15.5K |
|
|
FMI
2049
DELISTED
Foundation Medicine, Inc.
FMI
| $395K | ﹤0.01% |
+8,200
| New | +$372K |
|
|
DX
2050
Dynex Capital
DX
$3.21B
| $394K | ﹤0.01% |
15,532
+966
| +7% | +$24.2K |
|
Similar funds
UBS AM's Q1 2015 Portfolio in Review
As of Q1 2015, UBS AM held 2,695 positions worth $104B, down 1.3% from $105B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM withdrew a net $4.3B in Q1 2015, closing 72 positions and reducing 841 holdings. Its most notable exit was Allergan Inc, an estimated $221M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, UBS AM opened a new position in Qorvo worth $36M.
- UBS AM's largest Q1 2015 buy was Qorvo: 451,878 shares worth $36M.
- UBS AM added most to Allergan plc in Q1 2015, an estimated $321M increase.
- UBS AM's biggest Q1 2015 reduction was Walgreens Boots Alliance, cutting an estimated $251M.
- UBS AM fully exited Allergan Inc in Q1 2015, selling an estimated $221M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q1 2015.
- UBS AM opened 84 new positions and closed 72 in Q1 2015.
- UBS AM's portfolio value fell 1.3% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q1 2015, filed 4 May 2015.